By Rajnish Mago, MD (bio) THIS PAGE IS UNDER CONSTRUCTION Monoamine oxidase inhibitors (MAOIs) are infrequently used but remain an important class of antidepressant medications and an important option in so-called “difficult-to-treat” depression. Why are the infrequently used, probably less often than they should be? There are several reasons but the main reason is probably…